SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-015663
Filing Date
2019-08-27
Accepted
2019-08-27 16:06:44
Documents
12
Period of Report
2019-08-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 49940
  Complete submission text file 0001140361-19-015663.txt   195535

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA myov-20190823.xsd EX-101.SCH 4383
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE myov-20190823_lab.xml EX-101.LAB 24319
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myov-20190823_pre.xml EX-101.PRE 17287
5 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4378
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44(0)207 400 3347
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37929 | Film No.: 191057347
SIC: 2834 Pharmaceutical Preparations